Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Huntington Disease

glucose, (beta-d)-isomer has been researched along with Huntington Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
El-Sahar, AE; El-Yamany, MF; Rastanawi, AA; Saad, MA1
Allwood, JW; Bott, M; Braga, A; da Silva, MH; Dekker, W; Faria, N; Ferreira, P; Foito, A; Jardim, C; Kallscheuer, N; Marienhagen, J; Menezes, R; Naesby, M; Nunes Dos Santos, C; Oliveira, J; Ottens, M; Rocha, I; Rosado-Ramos, R; Sevillano, DM; Silva, AR; Sousa, M; Stewart, D1

Other Studies

2 other study(ies) available for glucose, (beta-d)-isomer and Huntington Disease

ArticleYear
Dapagliflozin improves behavioral dysfunction of Huntington's disease in rats via inhibiting apoptosis-related glycolysis.
    Life sciences, 2020, Sep-15, Volume: 257

    Topics: Animals; Apoptosis; Autophagy; Behavior, Animal; Benzhydryl Compounds; Disease Models, Animal; Glucosides; Glycolysis; Huntington Disease; Inflammation; Male; Maze Learning; Rats; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors

2020
Identification and Microbial Production of the Raspberry Phenol Salidroside that Is Active against Huntington's Disease.
    Plant physiology, 2019, Volume: 179, Issue:3

    Topics: Biosynthetic Pathways; Chemical Fractionation; Glucosides; Huntingtin Protein; Huntington Disease; Models, Biological; Phenols; Plant Extracts; Rubus; Saccharomyces cerevisiae

2019